GlaxoSmithKline said on Thursday it agreed to sell its entire stake in Unilever's Indian business for about 254.8 billion rupees ($3.35 billion)
on the open market, cashing in late from the sale of the Horlicks brand. (https://reut.rs/3fvie8r)

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Anil D'Silva)